The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy

Sweet, Erin; Dowd, Frederick; Zhou, May; Standish, Leanna J.; Andersen, M. Robyn

doi:10.1155/2016/4382687

Cited by 24 publications

(24 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Additional information about study procedures available in prior reports describing the cost and content of NO care provided to the NO cohort and reports of describing at-enrollment characteristics of our cohorts. 3 …”

Section: Methodsmentioning

confidence: 99%

“… 1 Some biologically based supplements should be evaluated in light of possible interactions with conventional treatments. 2 , 3 It is estimated that between 50% and 80% of cancer patients supplement their care with CAM treatments, while only a small percentage use naturopathic oncology (NO) and receive care from naturopathic doctors (NDs) with special training in oncology. While there is scientific evidence for many of the CAM treatments patients use, and NO providers offer their patients, a review of the literature found no studies describing the health and health-related quality of life (HRQOL) effects of NO care as commonly practiced in communities.…”

mentioning

confidence: 99%

See 1 more Smart Citation

Use of Integrative Oncology, Involvement in Decision-Making, and Breast Cancer Survivor Health-Related Quality of Life in the First 5 Years Postdiagnosis

et al. 2018

Self Cite

View full text Add to dashboard Cite

Objective: This study sought to describe changes in the health-related quality of life (HRQOL) of women who do and do not seek naturopathic oncology (NO) complementary and alternative medicine (CAM) care during and immediately after breast cancer treatment, and to explore the predictive role of NO CAM care, demographic characteristics, and involvement in decision-making on HRQOL in breast cancer survivors. Methods: Matched cohorts of breast cancer survivors who did and did not choose to supplement their breast cancer treatment with NO care within 2 years of diagnosis participated. NO users were identified through naturopathic doctors’ clinics and usual care (UC) controls with similar prognosis were identified through a cancer registry. The registry provided information about all participants’ age, race, ethnicity, marital status, stage of cancer at time of diagnosis, date of diagnosis, and use of conventional medical treatments (surgery, chemotherapy, radiation, and endocrine therapy). Data of participants’ self-reported involvement in decision-making and HRQOL were collected at study enrollment and at 6-month follow-up. Results: At 6-month follow-up, the NO patients reported significantly more involvement in decision-making about care and better general health than did UC patients (P < .05). Self-reported involvement in decision-making about cancer treatment was associated with better role-physical, role-emotional, and social-functional well-being (P < .05). Race, age, marital status, and congruence of preferred and achieved levels of involvement also predicted aspects of HRQOL in breast cancer survivors (P < .05). Conclusions: Both NO CAM care and involvement in decision-making about cancer treatment may be associated with better HRQOL in breast cancer survivors.

show abstract

Section: Methodsmentioning

confidence: 99%

mentioning

confidence: 99%

Use of Integrative Oncology, Involvement in Decision-Making, and Breast Cancer Survivor Health-Related Quality of Life in the First 5 Years Postdiagnosis

et al. 2018

Self Cite

View full text Add to dashboard Cite

show abstract

“…Use of dietary supplements, especially antioxidants, during chemotherapy and radiotherapy can influence the action of these treatments. Our earlier analysis using the same data set showed that women mostly used green tea (15.7%), melatonin (10.8%), vitamin C (11.4%), and vitamin E (10.6%) during these adjuvant treatments [24]. Forty-four percent of women used one or more dietary supplement potentially contraindicated during chemotherapy and 32% used antioxidants during radiation treatment.…”

Section: Discussionmentioning

confidence: 93%

“…Forty-four percent of women used one or more dietary supplement potentially contraindicated during chemotherapy and 32% used antioxidants during radiation treatment. And only 23.8% of the women who used antioxidants discussed their use with their medical doctors, while 42% discussed it with CAM providers [24]. Considering both Receivers and Refusers were self-prescribing most of these supplements except vitamin D and melatonin, it would be important to find out where women get the information about supplement use during cancer treatment.…”

Section: Discussionmentioning

confidence: 99%

Comparison of Dietary Supplements Use Between Receivers and Refusers of Adjuvant Breast Cancer Treatments

Standish¹,

Kim²,

Andersen³

2019

COR

View full text Add to dashboard Cite

The goal of this study was to compare dietary supplement use between women who received all recommended conventional breast cancer treatments (Receivers) with those who did not (Refusers). We sought to understand commonly used supplements, use frequency, and prescribers. Methods: A secondary analysis was conducted using baseline data of Breast Cancer Integrative Oncology Study, which recruited 369 women with breast cancer from integrative oncology clinics and Cancer Surveillance System registry in Western Washington State. Self-reported data and registry data were analyzed using descriptive statistics, t-tests, and X 2 tests to compare Receivers and Refusers in their demographic and disease characteristics and supplement use. Results: Refusers used more supplements than Receivers did after diagnosis, 5.43 ± 5.29 vs. 2.66 2.88, F = 26.32, p < 0.001. Refusers used more fish oil and garlic before diagnosis, and more green tea, vitamin C, melatonin, coenzyme Q10, turmeric, and garlic after the diagnosis than Receivers. Most Receivers and Refusers took supplements 5 or more days per week. Most of the supplements were self-prescribed except vitamin D and Melatonin, which were prescribed by medical doctors or CAM providers. Conclusions: Receivers and Refusers generally used the same top ten supplements, often antioxidants, although the frequency of use differed slightly, and Refusers took more supplements. Receivers, who are undergoing chemotherapy or radiotherapy need to know that taking antioxidants may influence treatment effectiveness. Refusers need to be informed that there is no strong evidence that the use of dietary supplements reduces recurrence or mortality.

show abstract

“…Außerdem wurde in der Literatur darüber berichtet, dass insbesondere Chemotherapiepatienten versuchen, mithilfe der integrativen Medizin ihre Nebenwirkungen zu vermindern [21,22]. Wir untersuchten daher die Fragestellung, ob bei unseren Patientinnen eine Besserung von Nebenwirkungen konventioneller Therapien und der selbstberichteten Lebensqualität erreicht werden konnte.…”

Section: Diskussionunclassified

Unterstützende Infusionen in der integrativen Onkologie bei Brustkrebs und gynäkologischen Krebserkrankungen – Bericht über die Zufriedenheit der Patientinnen sowie über selbstberichtete Wirkungen und Nebenwirkungen

Hack

Antoniadis

Beckmann

et al. 2019

Senologie - Zeitschrift für Mammadiagnostik und -therapie

View full text Add to dashboard Cite

Zusammenfassung Hintergrund Während einer Krebstherapie leiden viele Patienten an Mangelernährung oder Vitaminmangel. Die Behandlung nährstoffbezogener Mangelzustände sollte daher eine Ernährungstherapie und gegebenenfalls auch eine orale oder intravenöse Substitution von Mikronährstoffen beinhalten. Über Infusionstherapien mit mehreren Nährstoffen liegen nur wenige Informationen vor. Das Ziel dieser Studie bestand in der Entwicklung standardisierter Infusionsprotokolle für die Infusion von Mikronährstoffen im Rahmen der integrativen Medizin (IMed-Infusionen) und der Beschreibung von Nebenwirkungen der Behandlung und der Therapiezufriedenheit der Patientinnen. Methoden Für die IMed-Sprechstunde wurden in Zusammenarbeit mit der Apotheke des Universitätsklinikums Erlangen 4 spezielle Formulierungen für die intravenöse Anwendung entwickelt. Zwischen Oktober 2015 und Januar 2018 wurde eine retrospektive Querschnittsstudie durchgeführt, in der 45 Patientinnen mit gynäkologischen Krebserkrankungen oder Brustkrebs (BK) unter IMed-Infusionstherapie aufgenommen wurden. Von 20 Patientinnen wurden mithilfe eines standardisierten Fragebogens zu IMed-Infusionen Nachbeobachtungsdaten erhoben. Ergebnisse Während des Studienzeitraums wurden insgesamt 280 IMed-Infusionen verabreicht. Die meisten Patientinnen haben IMed-Regenerationsinfusionen erhalten (78 %). Die Patientinnen litten in der Mehrzahl der Fälle an BK und wurden mit Chemotherapie behandelt. Die meisten Patientinnen gaben ein hohes oder sehr hohes Maß an Zufriedenheit mit der Organisation (60 %), der allgemeinen Behandlung (65 %) und der Beratung (85 %) an. Über eine subjektive Besserung von krankheits- oder therapiebedingten Symptomen wie Fatigue, Polyneuropathie und Einschränkung der körperlichen Leistungsfähigkeit berichteten 70 % der Patientinnen, während 75 % eine subjektive Steigerung ihrer Lebensqualität angaben. Nebenwirkungen traten nur selten auf und waren leichter Natur. Schlussfolgerungen Die Therapie mit IMed-Infusionen bei Frauen mit BK oder gynäkologischen Krebserkrankungen muss denselben Standards genügen wie Arzneimitteltherapien. Obwohl es sich bei Vitaminen um Nahrungsergänzungsmittel handelt, sind eine gründliche Erhebung der Anamnese sowie eine angemessene Aufklärung der Patientinnen unerlässlich. Hierfür haben sich standardisierte Vorgehensweisen, wie im Rahmen der IMed-Sprechstunde der Fall, als hilfreich erwiesen.

show abstract

The Use of Complementary and Alternative Medicine Supplements of Potential Concern during Breast Cancer Chemotherapy

Cited by 24 publications

References 21 publications

Use of Integrative Oncology, Involvement in Decision-Making, and Breast Cancer Survivor Health-Related Quality of Life in the First 5 Years Postdiagnosis

Use of Integrative Oncology, Involvement in Decision-Making, and Breast Cancer Survivor Health-Related Quality of Life in the First 5 Years Postdiagnosis

Comparison of Dietary Supplements Use Between Receivers and Refusers of Adjuvant Breast Cancer Treatments

Unterstützende Infusionen in der integrativen Onkologie bei Brustkrebs und gynäkologischen Krebserkrankungen – Bericht über die Zufriedenheit der Patientinnen sowie über selbstberichtete Wirkungen und Nebenwirkungen

Contact Info

Product

Resources

About